1MED and Circular Global Ledgers Partner to Revolutionize Clinical Data Management with Blockchain Technology

September 03 2024

Agno, 03-09-2024

1MED, a leading Contract Research Organization (CRO), is proud to announce a groundbreaking partnership with Circular Global Ledgers, a cutting-edge Layer 1 blockchain platform, to enhance the integrity and security of clinical data collection in hospitals and during prospective studies.

This collaboration marks a significant milestone as 1MED becomes the first CRO to leverage blockchain technology for clinical research. Through this partnership, both organizations aim to set new standards in the management and protection of clinical data, ensuring that data remains tamper-proof and fully traceable.

Gianluca De Novi, CEO of Circular Global Ledgers, expressed his enthusiasm for the partnership:

“The integration of blockchain in clinical research is not just an advancement; it is a necessity. With Circular Global Ledgers, we are providing a robust, decentralized framework that ensures absolute data integrity and transparency. Partnering with 1MED, an industry leader in clinical research, allows us to bring this vision to life and to set a new standard for the healthcare industry.”

Enrico Perfler, Founder of 1MED, commented on the strategic importance of the collaboration:

“At 1MED, our mission has always been to uphold the highest standards of quality and reliability in clinical research. Partnering with Circular Global Ledgers enables us to elevate these standards further. By integrating blockchain technology into our processes, we are ensuring that every piece of data is securely recorded, immutable, and fully transparent. This not only enhances the credibility of our research but also provides unprecedented confidence to our clients and stakeholders.”

Key Benefits of the Partnership:

· Data Integrity: Blockchain technology ensures that all clinical data is digitally signed and stored in a decentralized network, making unauthorized modifications detectable and ensuring the authenticity of the records.

· Transparency and Traceability: Every change in the clinical records is meticulously tracked, providing a transparent audit trail that enhances the reliability of the data.

· Enhanced Security: By using blockchain, 1MED ensures that clinical data remains tamper-proof, significantly reducing the risk of data breaches and enhancing the overall security of patient information.

· Empowering Research: The use of blockchain opens new avenues for retrospective analyses, observational studies, and epidemiological research, ensuring that data integrity is maintained throughout.

This partnership is set to drive significant advancements in the field of clinical research, with both organizations committed to leading the charge in bringing innovative, secure, and reliable solutions to the healthcare industry.

About 1MED:

1MED is a leading Contract Research Organization (CRO) specializing in providing comprehensive services for clinical research, regulatory affairs, and quality assurance. With a commitment to excellence, 1MED partners with pharmaceutical, biotech, and medical device companies to bring innovative therapies to market.

About Circular Global Ledgers:

Circular Global Ledgers is a pioneering blockchain Layer 1 platform that focuses on providing decentralized solutions for a variety of industries. With an emphasis on security, transparency, and scalability, Circular Global Ledgers is at the forefront of leveraging blockchain technology to drive innovation across multiple sectors.